OVID Trademark

Trademark Overview

On Tuesday, December 8, 2015, a trademark application was filed for OVID with the United States Patent and Trademark Office. The USPTO has given the OVID trademark a serial number of 86842818. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 12, 2023. This trademark is owned by Ovid Therapeutics, Inc.. The OVID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product evaluation * for the treatment of rare neurological diseases and disorders * ; pharmaceutical products development * for the treatment of rare neurological diseases and disorders * ; pharmaceutical research and development * for the treatment of rare neurological diseases and disorders *
ovid

General Information

Serial Number86842818
Word MarkOVID
Filing DateTuesday, December 8, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 12, 2023
Registration Number5157380
Registration DateTuesday, March 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the Statement, the following class is updated per the Board Order dated 11/29/18: Class 42.
Goods and ServicesPharmaceutical product evaluation * for the treatment of rare neurological diseases and disorders * ; pharmaceutical products development * for the treatment of rare neurological diseases and disorders * ; pharmaceutical research and development * for the treatment of rare neurological diseases and disorders *

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 11, 2015
Primary Code042
First Use Anywhere DateMonday, June 27, 2016
First Use In Commerce DateMonday, June 27, 2016

Trademark Owner History

Party NameOvid Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameOvid Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameOvid Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, September 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, September 12, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 12, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 13, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, March 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 6, 2018TTAB RELEASE CASE TO TRADEMARKS
Thursday, December 6, 2018CANCELLATION TERMINATED NO. 999999
Monday, December 3, 2018AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Thursday, November 29, 2018CANCELLATION DENIED NO. 999999
Thursday, September 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 31, 2017CANCELLATION INSTITUTED NO. 999999
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, February 1, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, December 12, 2016USE AMENDMENT FILED
Wednesday, January 11, 2017SOU EXTENSION 1 GRANTED
Monday, December 12, 2016SOU EXTENSION 1 FILED
Saturday, January 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 12, 2016SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, June 28, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 24, 2016ASSIGNED TO EXAMINER
Friday, December 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 11, 2015NEW APPLICATION ENTERED

Related Keywords

ovid pharmaceutical diseases disorders rare neurological treatment development research product evaluation